
    
      The study is an 8-wk randomized, controlled, parallel arm clinical trial in which
      participants (age: 18-25 years, BMI: 25-45 kg/m2, race/ethnicity: Black or White) will be
      block randomized to a personalized dietary intervention or to receive conventional dietary
      advice. Outcomes assessed will include metabolites involved in carbohydrate and lipid
      regulation, gut microbiome composition, and cardiometabolic biomarkers.
    
  